The percentage of prostate‐specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years
![The percentage of prostate‐specific antigen (<scp>PSA</scp>) isoform [–2]pro<scp>PSA</scp> and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total <scp>PSA</scp> and percentage free <scp>PSA</scp> in men aged ≤65 years](https://img.exaly.com/article-chart/64441197/citations/graph.svg)
